Product Images Linezolid

This is a description of an intravenous injection solution called Linezolid. The solution contains 600mg of Linezolid per 300mL (2mg per mL) and is intended for single-use only. The solution contains linezolid, dextrose, sodium citrate, citric acid, and water for injection. The normal dose for adults is described in the package insert. The solution should not be used in series connections and should be checked for leakage. The solution should be stored between 20°C to 25°C (68°F to 77°F) and should not be frozen. The description also provides information about the manufacturer, including the lot number and expiration date.*

This is a description for Linezolid Injection, indicated for intravenous infusion use only for adults. It is used immediately once removed from the overwrap that serves as a moisture barrier and stored at a controlled room temperature not exceeding 25°C. It is not advisable to use in series connections and to add supplementary medication to avoid sterility impairment. The container closure does not contain natural rubber latex and is manufactured in Norway. However, the dosage and exact indications are found in the package insert.*

This appears to be a label for the drug "Linezolid" in injection form for intravenous infusion. It is only available for prescription (Rx Only). The product code is 01-78-12-010A and the label also includes another code of 403068A. No further information can be provided due to the limited text.*

Product No. 713013 is an injectable solution manufactured by Fresenius under the name Linezolid. Each 300 mL bottle contains 600 mg of the active ingredient (2 mg per mL). The product should be stored at a temperature between 20 to 25°C and should not be frozen. It is sensitive to light. The product is labeled with the NDC code of 63323-713-13 and has an expiration date (MM-DD-YYYY) and lot number. The product is for prescription use only and was made in Norway.*